Literature DB >> 32523889

A Survey of UK Centres on Low Iodine Diet Recommendations prior to Radioiodine Ablation Therapy for Differentiated Thyroid Cancer.

Clare Yvonne England1,2, Laura Moss3, Matthew Beasley4, Ingrid Haupt-Schott3, Georgia Herbert1, Charlotte Atkinson1.   

Abstract

BACKGROUND: Guidelines suggest that a low iodine diet (LID) is advised prior to radioiodine ablation (RIA) for thyroid cancer. We aim to describe current practice regarding LID advice in the UK, determine uptake of the 2016 UK LID Working Group diet sheet and discover whether there are differences in practice.
METHODS: We used an online survey distributed between November 2018 and April 2019 to centres in the UK that administer <sup>131</sup>I. We asked questions on whether a LID is advised, for how long, how advice is presented, whether and how compliance is measured and whether treatment is delayed if LID advice is not followed.
RESULTS: Fifty-six clinicians from 47 centres that carry out RIA for thyroid cancer responded. Forty-four centres (94%) advise a LID prior to RIA, the majority for 14 days (82%). Two-thirds of the centres use the UK LID Working Group diet sheet. Patients are told to resume normal eating when <sup>131</sup>I is administered at 17 centres (39%), with 18 (41%) advising waiting for 24-48 h after administration. Most centres (95%) use only a simple question or do not assess compliance. Only 2 (5%) indicate that RIA would be delayed if someone said they had not followed LID advice.
CONCLUSIONS: UK practice regarding LID prior to RIA for thyroid cancer is consistent with current guidelines, but non-adherence does not usually delay RIA. The UK Low Iodine Diet Working Group diet sheet is widely recognised and used. Practice could be improved by centres working to harmonise advice on when to restart a normal diet.
Copyright © 2019 by S. Karger AG, Basel.

Entities:  

Keywords:  Low iodine diet; Radioiodine ablation; Survey; Thyroid cancer

Year:  2019        PMID: 32523889      PMCID: PMC7265714          DOI: 10.1159/000504706

Source DB:  PubMed          Journal:  Eur Thyroid J        ISSN: 2235-0640


  18 in total

Review 1.  Dietary iodine restriction in preparation for radioactive iodine treatment or scanning in well-differentiated thyroid cancer: a systematic review.

Authors:  Anna M Sawka; Irada Ibrahim-Zada; Philip Galacgac; Richard W Tsang; James D Brierley; Shereen Ezzat; David P Goldstein
Journal:  Thyroid       Date:  2010-10       Impact factor: 6.568

2.  Estimating risk of recurrence in differentiated thyroid cancer after total thyroidectomy and radioactive iodine remnant ablation: using response to therapy variables to modify the initial risk estimates predicted by the new American Thyroid Association staging system.

Authors:  R Michael Tuttle; Hernan Tala; Jatin Shah; Rebecca Leboeuf; Ronald Ghossein; Mithat Gonen; Matvey Brokhin; Gal Omry; James A Fagin; Ashok Shaha
Journal:  Thyroid       Date:  2010-10-29       Impact factor: 6.568

3.  The success rate of initial (131)i ablation in differentiated thyroid cancer: comparison between less strict and very strict low iodine diets.

Authors:  Ik Dong Yoo; Sung Hoon Kim; Ye Young Seo; Jin Kyoung Oh; Joo Hyun O; Soo Kyo Chung
Journal:  Nucl Med Mol Imaging       Date:  2011-10-08

Review 4.  Low iodine diet in differentiated thyroid cancer: a review.

Authors:  Josephine H Li; Zhiheng H He; Vivek Bansal; James V Hennessey
Journal:  Clin Endocrinol (Oxf)       Date:  2015-07-29       Impact factor: 3.478

5.  Effects of low-iodide diet on postsurgical radioiodide ablation therapy in patients with differentiated thyroid carcinoma.

Authors:  Maurice J H M Pluijmen; Carmen Eustatia-Rutten; Bernard M Goslings; Marcel P Stokkel; Alberto M Pereira Arias; Michaela Diamant; Johannes A Romijn; Jan W A Smit
Journal:  Clin Endocrinol (Oxf)       Date:  2003-04       Impact factor: 3.478

6.  Guidelines for radioiodine therapy of differentiated thyroid cancer.

Authors:  M Luster; S E Clarke; M Dietlein; M Lassmann; P Lind; W J G Oyen; J Tennvall; E Bombardieri
Journal:  Eur J Nucl Med Mol Imaging       Date:  2008-10       Impact factor: 9.236

7.  Experiences with a low-iodine diet: A qualitative study of patients with thyroid cancer receiving radioactive iodine therapy.

Authors:  Kyem Ju Lee; Sung Ok Chang; Kwang Yoon Jung
Journal:  Eur J Oncol Nurs       Date:  2016-05-07       Impact factor: 2.398

8.  Association between excessive urinary iodine excretion and failure of radioactive iodine thyroid ablation in patients with papillary thyroid cancer.

Authors:  Seo Young Sohn; Joon Young Choi; Hye Won Jang; Hye Jeong Kim; Sang Man Jin; Se Won Kim; Sunghwan Suh; Kyu Yeon Hur; Jae Hyeon Kim; Jae Hoon Chung; Sun Wook Kim
Journal:  Thyroid       Date:  2013-06       Impact factor: 6.568

Review 9.  Systematic review of studies evaluating urinary iodine concentration as a predictor of 24-hour urinary iodine excretion for estimating population iodine intake.

Authors:  Chen Ji; Tammy Lu; Omar Dary; Branka Legetic; Norm R Campbell; Francesco P Cappuccio
Journal:  Rev Panam Salud Publica       Date:  2015-07

10.  Guidelines for the management of thyroid cancer.

Authors:  Petros Perros; Kristien Boelaert; Steve Colley; Carol Evans; Rhordi M Evans; Georgina Gerrard Ba; Jackie Gilbert; Barney Harrison; Sarah J Johnson; Thomas E Giles; Laura Moss; Val Lewington; Kate Newbold; Judith Taylor; Rajesh V Thakker; John Watkinson; Graham R Williams
Journal:  Clin Endocrinol (Oxf)       Date:  2014-07       Impact factor: 3.478

View more
  1 in total

1.  Low-Iodine Diet of 4 Days Is Sufficient Preparation for 131I Therapy in Differentiated Thyroid Cancer Patients.

Authors:  Bernadette L Dekker; Mirthe H Links; Anneke C Muller Kobold; Linda G Swart-Busscher; Marleen Kars; Judith A P Bons; Adrienne H Brouwers; Thera P Links; Anouk N A van der Horst-Schrivers
Journal:  J Clin Endocrinol Metab       Date:  2022-01-18       Impact factor: 5.958

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.